AcceleraRomar Division Acquired in Management-Led Buyout
Name Changed to Red Nucleus

Hamilton, NJ, January 2, 2008 - AcceleraRomar's clinical training division announced today that it was acquired in a management-led buyout from Alpha Genesis, LLC, and is immediately changing its name to Red Nucleus. All assets of the division, including off-the-shelf training programs, were acquired by Ian Kelly and Andrew Howe, who are assuming the titles of President and Chief Operating Officer, respectively.

"Our buyout will have many benefits for our clients," stated Red Nucleus President Ian Kelly. "With our new structure we will be much more nimble and efficient in the development of our programs. Additionally, we plan to greatly increase our R&D to ensure that we are leading the innovation in pharmaceutical sales training."

About Red Nucleus Solutions
Red Nucleus, formerly the clinical training division of AcceleraRomar, creates interactive e-learning, print-based, workshop, and blended solutions for the life sciences industry. Red Nucleus' consultative approach, expertise in adult learning, and access to world-class medical content offer its clients unique advantages for the enhancement of their organizational performance. Company leadership has been active in the learning field for more than 15 years.